Functional significance of genetic abnormalities in multiple myeloma

被引:4
作者
Gadó, K
Domján, G
Kormos, L
Falus, A
机构
[1] Semmelweis Univ, Fac Med, Dept Genet Cell & Immunobiol, H-1089 Budapest, Hungary
[2] St Rokus Hosp, Dept Med 1, Budapest, Hungary
[3] St Laszlo Hosp, Budapest, Hungary
关键词
multiple myeloma; genetic alterations; chromosomal abnormalities;
D O I
10.1163/15685590260461011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Multiple myeloma (MM) is a B-cell neoplasm characterized by infiltration of the bone marrow with malignant plasma cells, synthesizing and secreting monoclonal immunoglobulin fragments. The malignant transformation of this terminally differentiated plasma cell is the result of a multistep transformation process. In spite of recent advances in this field, the cause and the exact molecular genetic basis of MM remain obscure. In this review, an attempt has been made to summarize the genetic alterations having functional significance in the generation and progression of MM, and also the existing relationship between genetic abnormalities and chemosensitivity, as well as the typical genetic alterations in various MM subgroups. Factors known to have a role in the conversion of monoclonal gammopathy of unknown significance (MGUS) to MM are also reviewed.
引用
收藏
页码:191 / 208
页数:18
相关论文
共 78 条
[1]  
Albin N, 1997, B CANCER, V84, P643
[2]   Advances in disease biology: Therapeutic implications [J].
Anderson, KC .
SEMINARS IN HEMATOLOGY, 2001, 38 (02) :6-10
[3]  
Anderson KC, 1999, SEMIN HEMATOL, V36, P3
[4]   Monosomy 13 is associated with the transition of monoclonal gammopathy of undetermined significance to multiple myeloma [J].
Avet-Loiseau, H ;
Li, JY ;
Morineau, N ;
Facon, T ;
Brigaudeau, C ;
Harousseau, JL ;
Grosbois, B ;
Bataille, R .
BLOOD, 1999, 94 (08) :2583-2589
[5]  
Banerjee D, 2001, Curr Opin Investig Drugs, V2, P574
[6]   High-dose therapy and innovative approaches to treatment of multiple myeloma [J].
Barlogie, B .
SEMINARS IN HEMATOLOGY, 2001, 38 (02) :21-27
[7]   REGULATION OF INTERLEUKIN-6, OSTEOCLASTOGENESIS, AND BONE MASS BY ANDROGENS THE ROLE OF THE ANDROGEN RECEPTOR [J].
BELLIDO, T ;
JILKA, RL ;
BOYCE, BF ;
GIRASOLE, G ;
BROXMEYER, H ;
DALRYMPLE, SA ;
MURRAY, R ;
MANOLAGAS, SC .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (06) :2886-2895
[8]   Association between the SDF1-3′A allele and high levels of CD34+ progenitor cells mobilized into peripheral blood in humans [J].
Benboubker, L ;
Watier, H ;
Carion, A ;
Georget, MT ;
Desbois, I ;
Colombat, P ;
Bardos, P ;
Binet, C ;
Domenech, J .
BRITISH JOURNAL OF HAEMATOLOGY, 2001, 113 (01) :247-250
[9]  
BERGSAGEL D, 1995, STEM CELLS, V13, P1
[10]   Chromosome translocations in multiple myeloma [J].
Bergsagel, PL ;
Kuehl, WM .
ONCOGENE, 2001, 20 (40) :5611-5622